Acquisitions & Mergers

Natco to Acquire 35.75% of Adcock Ingram for ₹1,970 Cr

By Neelesh Pandey - 24 Jul 2025 04:08 PM

Indian drugmaker Natco Pharma has announced plans to acquire a 35.75% stake in Adcock Ingram, one of South Africa’s largest pharmaceutical companies, for ₹1,970 crore (around $236 million). This move marks a major step in Natco’s efforts to expand beyond India and reach more patients globally.

The deal will be carried out through Natco’s subsidiary, Natco Pharma Africa (Pty) Ltd, and is still subject to regulatory approvals in South Africa and India. Once completed, this would give Natco a strong foothold in the South African market.

Adcock Ingram is a well-established name in the region, producing a wide range of medicines including over-the-counter products, prescription drugs, and hospital treatments. For Natco, the partnership is expected to bring long-term growth and access to a broader market.

In a statement, Natco said this investment aligns with its plan to grow internationally in a sustainable way. The deal also reflects a shift by Indian pharma companies toward building a stronger global presence, especially in emerging markets.